Patient-reported outcomes (PRO) in cancer trials submitted to the FDA from 2012-2015.

被引：6
|
作者：
Kanapuru, Bindu
Singh, Harpreet
Kim, Janice
Kluetz, Paul Gustav
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e14024
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14024
引用
收藏
页数：5
相关论文
共 50 条
  • [21] The prognostic significance of patient-reported outcomes in cancer clinical trials
    Gotay, Carolyn C.
    Kawamoto, Crissy T.
    Bottomley, Andrew
    Efficace, Fabio
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (08) : 1355 - 1363
  • [22] Patient-reported outcomes (PRO) in ovarian cancer clinical trials-lost opportunities and lessons learned
    Friedlander, M.
    Mercieca-Bebber, R. L.
    King, M. T.
    ANNALS OF ONCOLOGY, 2016, 27 : 66 - 71
  • [23] Beyond the FDA PRO Guidance: Steps toward Integrating Meaningful Patient-Reported Outcomes into Regulatory Trials and US Drug Labels
    Basch, Ethan
    VALUE IN HEALTH, 2012, 15 (03) : 401 - 403
  • [24] Patient-Reported Outcomes, Patient-Reported Information From Randomized Controlled Trials to the Social Web and Beyond
    Baldwin, Mike
    Spong, Andrew
    Doward, Lynda
    Gnanasakthy, Ari
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2011, 4 (01): : 11 - 17
  • [25] Meeting on the FDA draft guidance on patient-reported outcomes
    Dueck, Amylou C.
    Sloan, Jeff A.
    VALUE IN HEALTH, 2007, 10 : S64 - S65
  • [26] Patient-reported outcomes in breast cancer FDA drug labels and review documents
    Kyungwan Hong
    Kayleigh R. Majercak
    Ester Villalonga-Olives
    Eleanor M. Perfetto
    Journal of Patient-Reported Outcomes, 5
  • [27] Patient-reported outcomes in breast cancer FDA drug labels and review documents
    Hong, Kyungwan
    Majercak, Kayleigh R.
    Villalonga-Olives, Ester
    Perfetto, Eleanor M.
    JOURNAL OF PATIENT-REPORTED OUTCOMES, 2021, 5 (01)
  • [28] Learning from Patients: Reflections on Use of Patient-Reported Outcomes in Lung Cancer Trials
    Roy, Upal Basu
    King-Kallimanis, Bellinda L.
    Kluetz, Paul G.
    Selig, Wendy
    Ferris, Andrea
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : 1815 - 1817
  • [29] An FDA example of patient-reported Physical Function (PF) analysis in cancer clinical trials
    Strazzeri, Marian
    Johnson, Laura Lee
    Sridhara, Rajeshwari
    Kluetz, Paul
    Komo, Scott
    QUALITY OF LIFE RESEARCH, 2017, 26 (01) : 141 - 141
  • [30] Core Patient-Reported Outcomes for Trials in Nephrology
    Hughes, Anastasia
    Scholes-Robertson, Nicole
    Ju, Angela
    Jaure, Allison
    SEMINARS IN NEPHROLOGY, 2024, 44 (3-4)
12345